Patent details
EP3937914 Title: CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID
Basic Information
- Publication number:
- EP3937914
- PCT Application Number:
- GB2020050638
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207126731
- PCT Publication Number:
- WO2020188255
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID
- French Title of Invention:
- TRAITEMENT CONTRE LE CANCER COMPRENANT DE LA NALTREXONE ET UN CANNABINOÏDE
- German Title of Invention:
- KREBSBEHANDLUNG MIT NALTREXON UND EINEM CANNABINOID
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/09/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/09/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/08/2023
- Unitary Effect Registration Date:
- 11/09/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 13/03/2020
- Grant date:
- 09/08/2023
- EP Publication Date:
- 19/01/2022
- PCT Publication Date:
- 24/09/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/08/2023
- EP B1 Publication Date:
- 09/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 13/03/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/08/2023
- Name:
- LDN Pharma Limited
- Address:
- 45 Gresham Street, London EC2V 7BG, United Kingdom (GB)
Inventor
1
- Name:
- LIU, Wai
- Address:
- United Kingdom (GB)
2
- Name:
- DALGLEISH, Angus
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 201903546
- Priority Date:
- 15/03/2019
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 31/05; A61K 31/08; A61K 31/192; A61K 31/352; A61K 31/485; A61K 45/06; A61P 35/00; A61K 31/555; A61K 31/7068;
Publication
European Patent Bulletin
1
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|